Bumetanide 25021-0321-04
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA074441
Need to source Bumetanide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bumetanide | .25 mg/mL |
Drug Class
Loop Diuretic [EPC]Increased Diuresis at Loop of Henle [PE]Loop Diuretic [EPC]
Selected Package
25021-0321-04Selected10 VIAL in 1 CARTON (25021-321-04) / 4 mL in 1 VIAL
Other packages for this product(1)
10 VIAL in 1 CARTON (25021-321-10) / 10 mL in 1 VIAL